【レポートの概要（一部）】
TABLE OF CONTENTS
1 INTRODUCTION 24
1.1 OBJECTIVES OF THE STUDY 24
1.2 MARKET DEFINITION 24
1.3 MARKET SCOPE 25
1.3.1 MARKETS COVERED 25
1.3.2 YEARS CONSIDERED FOR THE STUDY 26
1.4 CURRENCY 26
1.5 LIMITATIONS 26
1.6 STAKEHOLDERS 26
2 RESEARCH METHODOLOGY 27
2.1 MARKET SIZE ESTIMATION 28
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 30
2.3 KEY DATA FROM SECONDARY SOURCES 32
2.4 KEY DATA FROM PRIMARY SOURCES 33
2.5 ASSUMPTIONS FOR THE STUDY 33
3 EXECUTIVE SUMMARY 34
4 PREMIUM INSIGHTS 37
4.1 INJECTABLE DRUG DELIVERY: MARKET OVERVIEW 37
4.2 INJECTABLE DRUG DELIVERY MARKET, BY FACILITY OF USE 37
4.3 GEOGRAPHIC ANALYSIS: INJECTABLE DRUG DELIVERY MARKET, BY SITE OF ADMINISTRATION 38
4.4 INJECTABLE DRUG DELIVERY MARKET, BY FORMULATION PACKAGING 38
4.5 GEOGRAPHICAL SNAPSHOT: INJECTABLE DRUG DELIVERY MARKET 39
5 MARKET OVERVIEW 40
5.1 INTRODUCTION 41
5.2 MARKET DYNAMICS 41
5.2.1 DRIVERS 42
5.2.1.1 Rising prevalence of chronic diseases 42
5.2.1.2 Increase in demand for self-injection devices 42
5.2.1.3 Growth in the biologics market 43
5.2.1.4 Technological advancements and new product launches 43
5.2.2 RESTRAINTS 44
5.2.2.1 Infections associated with needlestick injuries 44
5.2.2.2 Product recalls 45
5.2.3 OPPORTUNITIES 45
5.2.3.1 Increase in demand for biosimilar and generic injectables 45
5.2.3.1.1 Biosimilars 45
5.2.3.1.2 Generic injectables 46
5.2.3.2 Contraceptive injectables 47
5.2.4 CHALLENGE 48
5.2.4.1 Preference for other modes of drug delivery 48
6 REGULATORY SCENARIO 49
6.1 INTRODUCTION 49
6.2 FDA AND CE APPROVALS 49
6.3 THE EUROPEAN MEDICINES AGENCY (EMA) 50
6.4 CLINICAL TRIALS 50
7 INJECTABLE DRUG DELIVERY MARKET, BY TYPE 51
7.1 INTRODUCTION 52
7.2 DEVICES 52
7.2.1 CONVENTIONAL INJECTION DEVICES 53
7.2.1.1 By Material 54
7.2.1.1.1 Glass 55
7.2.1.1.2 Plastic 56
7.2.1.2 By Product 57
7.2.1.2.1 Fillable syringes 57
7.2.1.2.2 Prefilled syringes 58
7.2.1.3 By Usability 59
7.2.1.3.1 Reusable injection devices 59
7.2.1.3.2 Disposable injection devices 60
7.2.2 SELF-INJECTION DEVICES 61
7.2.2.1 Needle-free Injectors 62
7.2.2.1.1 By product 63
7.2.2.1.1.1 Fillable needle-free injectors 63
7.2.2.1.1.2 Prefilled needle-free injectors 64
7.2.2.1.2 By technology 65
7.2.2.1.2.1 Jet-based needle-free injectors 65
7.2.2.1.2.2 Spring-based needle-free injectors 66
7.2.2.1.2.3 Laser-powered needle-free injectors 67
7.2.2.1.2.4 Vibration-based needle-free injectors 68
7.2.2.1.3 By usability 68
7.2.2.1.3.1 Reusable needle-free injectors 69
7.2.2.1.3.2 Disposable needle-free injectors 69
7.2.2.2 Autoinjectors 70
7.2.2.2.1 By Product 71
7.2.2.2.1.1 Fillable autoinjectors 71
7.2.2.2.1.2 Prefilled autoinjectors 72
7.2.2.2.2 By Technology 72
7.2.2.2.2.1 Automated autoinjectors 73
7.2.2.2.2.2 Manual autoinjectors 73
7.2.2.2.3 By Design 74
7.2.2.2.3.1 Standardized autoinjectors 74
7.2.2.2.3.2 Customized autoinjectors 75
7.2.2.2.4 By Usability 76
7.2.2.2.4.1 Reusable autoinjectors 76
7.2.2.2.4.2 Disposable autoinjectors 77
7.2.2.3 Pen injectors 77
7.2.2.3.1 By Product 78
7.2.2.3.1.1 Single-chambered pen injectors 79
7.2.2.3.1.2 Dual-chambered pen injectors 79
7.2.2.3.2 By Design 80
7.2.2.3.2.1 Standard pen injectors 81
7.2.2.3.2.2 Customized pen injectors 81
7.2.2.3.3 By Usability 82
7.2.2.3.3.1 Reusable pen injectors 82
7.2.2.3.3.2 Disposable pen injectors 83
7.2.2.4 Wearable injectors 83
7.2.2.5 Other Devices 84
7.3 FORMULATIONS 85
7.3.1 CONVENTIONAL DRUG DELIVERY FORMULATIONS 86
7.3.1.1 Solutions 87
7.3.1.2 Reconstituted/lyophilized formulations 87
7.3.1.3 Suspensions 88
7.3.1.4 Emulsions 89
7.3.2 NOVEL DRUG DELIVERY FORMULATIONS 89
7.3.2.1 Colloidal dispersions 91
7.3.2.1.1 Niosomes 91
7.3.2.1.2 Liposomes 92
7.3.2.1.3 Polymeric/mixed micelles 93
7.3.2.1.4 Nanoparticles 93
7.3.2.1.4.1 Solid-lipid nanoparticles 95
7.3.2.1.4.2 Nanosuspensions 95
7.3.2.1.4.3 Nanoemulsions 96
7.3.2.2 Microparticles 96
7.3.2.2.1 Microspheres 97
7.3.2.2.2 Microcapsules 98
7.3.3 LONG-ACTING INJECTION FORMULATIONS 98
8 INJECTABLE DRUG DELIVERY MARKET, BY FORMULATION PACKAGING 100
8.1 INTRODUCTION 101
8.2 AMPULES 102
8.3 VIALS 102
8.4 CARTRIDGES 103
8.5 BOTTLES 103
9 INJECTABLE DRUG DELIVERY MARKET, BY THERAPEUTIC APPLICATION 104
9.1 INTRODUCTION 105
9.2 AUTOIMMUNE DISEASES 105
9.2.1 RHEUMATOID ARTHRITIS 107
9.2.2 MULTIPLE SCLEROSIS (MS) 108
9.2.3 CROHN’S DISEASE 108
9.2.4 PSORIASIS 109
9.2.5 OTHER AUTOIMMUNE DISEASES 110
9.3 HORMONAL DISORDERS 111
9.3.1 DIABETES 112
9.3.2 ANEMIA 113
9.3.3 REPRODUCTIVE HEALTH DISEASE 114
9.3.4 ANTITHROMBOTIC/THROMBOLYTIC THERAPY 115
9.3.5 OSTEOPOROSIS 115
9.3.6 GROWTH HORMONE DEFICIENCY (GHD) 116
9.4 ORPHAN DISEASES 117
9.5 CANCER 118
9.6 OTHER THERAPEUTIC APPLICATIONS 119
9.6.1 PAIN MANAGEMENT 120
9.6.2 ALLERGIES 121
9.6.3 AESTHETIC TREATMENT 122
9.6.4 HEPATITIS C 123
9.6.5 HEMOPHILIA 124
10 INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN 125
10.1 INTRODUCTION 126
10.2 CURATIVE CARE 126
10.3 IMMUNIZATION 128
10.4 OTHERS 128
11 INJECTABLE DRUG DELIVERY MARKET, BY SITE OF ADMINISTRATION 130
11.1 INTRODUCTION 131
11.2 SKIN (INTRADERMAL AND SUBCUTANEOUS) 132
11.3 CIRCULATORY/MUSCULOSKELETAL SYSTEM (INTRAVENOUS, INTRACARDIAC, INTRAMUSCULAR, AND INTRAPERITONEAL) 133
11.4 ORGANS (INTRAVITREAL AND INTRA-ARTICULAR) 134
11.5 CENTRAL NERVOUS SYSTEM (INTRACEREBRAL AND INTRATHECAL) 135
12 INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 136
12.1 INTRODUCTION 137
12.2 HOSPITALS 137
12.3 RETAIL PHARMACY STORES 138
13 INJECTABLE DRUG DELIVERY MARKET, BY FACILITY OF USE 139
13.1 INTRODUCTION 140
13.2 HOSPITALS AND CLINICS 141
13.3 HOME CARE SETTINGS 142
13.4 OTHER FACILITIES OF USE 143
14 INJECTABLE DRUG DELIVERY MARKET, BY REGION 144
14.1 INTRODUCTION 145
14.2 NORTH AMERICA 146
14.2.1 U.S. 151
14.2.2 CANADA 155
14.3 EUROPE 160
14.3.1 GERMANY 165
14.3.2 FRANCE 169
14.3.3 U.K. 173
14.3.4 ITALY 177
14.3.5 SPAIN 180
14.3.6 REST OF EUROPE (ROE) 184
14.4 ASIA 188
14.4.1 CHINA 194
14.4.2 JAPAN 197
14.4.3 INDIA 201
14.4.4 REST OF ASIA 206
14.5 REST OF THE WORLD (ROW) 210
15 COMPETITIVE LANDSCAPE 215
15.1 OVERVIEW 215
15.2 MARKET SHARE ANALYSIS 216
15.3 COMPETITIVE SITUATION AND TRENDS 217
15.3.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 218
15.3.2 PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS 218
15.3.1 EXPANSIONS 219
15.3.2 ACQUISITIONS 220
16 COMPANY PROFILES 221
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
16.1 INTRODUCTION 221
16.2 BAXTER INTERNATIONAL, INC. 222
16.3 BECTON, DICKINSON AND COMPANY 224
16.4 GERRESHEIMER AG 227
16.5 PFIZER, INC. 230
16.6 SCHOTT AG 233
16.7 ELI LILLY AND COMPANY 236
16.8 SANDOZ (A DIVISION OF NOVARTIS AG) 238
16.9 TERUMO CORPORATION 241
16.10 TEVA PHARMACEUTICAL INDUSTRIES LTD. 243
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
17 APPENDIX 245
17.1 INSIGHTS FROM INDUSTRY EXPERTS 245
17.2 DISCUSSION GUIDE 246
17.3 OTHER RECENT DEVELOPMENTS 250
17.4 AVAILABLE CUSTOMIZATIONS 251
17.5 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 252
17.6 RT: REAL-TIME MARKET INTELLIGENCE 254
17.7 RELATED REPORTS 255
17.8 AUTHOR DETAILS 256
【レポート販売概要】
■ タイトル：注射可能薬剤送達の世界市場予測（～2021年）■ 英文：Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel (Hospital), Patient Care Setting (Hospital, Home Care) - Forecast to 2021
■ 発行日：2017年2月6日
■ 調査会社：MarketsandMarkets
■ 商品コード：MAM-MD-3680
■ 調査対象地域：グローバル
- パワーアンプ（電力増幅器）の世界市場2016-2020About Amplifier An amplifier increases the power of a signal by taking power from a power supply. It alters the output to match with the shape of the input signal with high amplitude. It receives a signal from the information source and provides a bigger variant of the signal to some yield gadget or to another enhancer amplifiers. A voltage enhancer gives voltage intensification fundamentally to b …
- 天然繊維複合材料の世界市場The natural fiber composites market is projected to register a CAGR of 12.31% between 2014 and 2019 to reach $5,838.99 million by 2019. North America held the largest share in 2013 with the U.S. being the leading country. In the less explored markets of Asia-Pacific and Oceania, high growth is expected while the highly developed North American and European regions are predicted to show moderate to …
- モバイル・アナリティクスの世界市場2016-2020About the Mobile Analytics Market Mobile analytics is used to analyze the mobile website traffic like traditional analytics. It involves the use of data collected as visitors access a website from their mobile devices. It helps to determine which mobile marketing campaigns work best for the business and which aspects of the websites work best for the mobile traffic, including mobile search marketi …
- グローバル高温ガス炉（HTGR）/高温工学試験研究炉（HTTR）技術市場Global Overview of Opportunities and Key Developments in HTTR/HTGR Technology Summary Post-Fukushima, rising concern for human and environmental safety has seen countries invest in Generation IV (Gen IV) nuclear reactors such as High-Temperature Gas-Cooled Reactors and High-Temperature Test Reactors (HTGR/HTTR), which are safer and more efficient than traditional nuclear reactors. China is the lea …
- ホーム装飾材料の世界市場2015-2019About Home Decorative Materials Home decorative materials constitute products that enhance the appearance and durability of home interior surfaces such as walls and wood. These products have gradually transformed in terms of form and function, driven by advances in technology. The performance of the market is directly related to the housing sector. Ownership patterns and construction activity are …
- プレキャスト建設の世界市場予測（～2021年）MarketsandMarkets projects that the precast construction market size will grow from USD 124.77 Billion in 2015 to USD 177.09 Billion by 2021, at an estimated CAGR of 6.10%. The precast construction market is expected to witness high growth as a result of the rise in urbanization, large-scale investments in infrastructure & industrial sectors, and growth in construction activities in emerging econo …
- 小麦グルテンの世界市場Wheat Gluten (CAS 8002-80-0) Market Research Report 2014 presents comprehensive data on wheat gluten markets globally and regionally (Europe, Asia, North America etc.) The report includes wheat gluten description, covers its application areas and related patterns. It overviews wheat gluten market, names wheat gluten producers and indicates its suppliers. Besides, the report provides wheat gluten p …
- 商用車の世界市場2018-2022About Commercial Vehicle Commercial vehicles are used to carry passengers and transport goods. Commercial vehicles include pickup trucks, minibuses, large buses, coaches, body chassis, lorries, light trucks, heavy trucks, trailers, and semi-trailers. Technavio’s analysts forecast the global commercial vehicle market to grow at a CAGR of 4.97% during the period 2018-2022. Covered in this report The …
- 中国の使い捨て病院用品市場見通し（～2021）China Disposable Hospital Supplies Market Outlook to 2021 Summary GlobalData’s new report, "China Disposable Hospital Supplies Market Outlook to 2021", provides key market data on the China Disposable Hospital Supplies market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Procedure Kits and Trays, Gloves, Dr …
- 自動ラストマイルデリバリーの世界市場予測（～2030年）Technological advancements in the drone technology and rising demand for autonomous last mile delivery applications are the major factors driving the growth of the autonomous last mile delivery market, globally The autonomous last mile delivery market size is expected to grow from USD 12.0 billion in 2019 to USD 91.5 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 20.3% during the fore …
- 世界のクリーンルーム消耗品市場動向：Global Cleanroom Consumables Market 2014-2018TechNavio forecasts The Global Cleanroom Consumables Market 2014-2018 with a CAGR of 4.95 percent for the period 2013-2018. Several driving factors and trends will contribute to this growth-all of which will be outlined with detail in this report. TechNavio’s analysts use a unique methodology to scrutinize individual vendor performance, trends, drivers and challenges, and a number of other factors …
- 世界主要国におけるライノウイルス検査市場2015The report presents a detailed analysis of the Rhinovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Rhinovirus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Co …
- Total S.A.社の石油・ガス開発・生産動向及びコスト分析（2013年第4四半期）Total S.A. Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Total S.A. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational d …
- 肝胆道疾患(Hepatobiliary Disease)：世界の治験レビュー（2015年上半期版）Hepatobiliary Disease Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Hepatobiliary Disease Global Clinical Trials Review, H1, 2015" provides data on the Hepatobiliary Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatobiliary Disease. It includes an overview of the trial numbers and the …
- 蛋白質成分の世界市場：動物性蛋白質、植物性蛋白質About Protein Ingredients Protein ingredients are protein-rich materials used as ingredients in food, beverages, and feed products such as dietary supplements, sports nutrition products, bakery products, dairy products, ready meals, infant formula, and desserts. They are rich in nutrients with the correct amount of amino acids, and they provide essential nutrients to humans and animals. They are a …
